Kymriah Poised For Expansion In Follicular Lymphoma, Leveling The Field With Yescarta

 
• By Jessica Merrill

Novartis will present data from the pivotal Phase II ELARA trial of the CAR-T therapy in relapsed/refractory follicular lymphoma at ASCO.

chess board
Kymriah aims to keep a level board with Yescarta • Source: Alamy

More from Anticancer

More from Therapy Areas